| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Revenue | $36.9M | +7.0% |
| Cost of Revenue | $19.7M | +2.6% |
| Gross Profit | $17.2M | +12.5% |
| R&D Expense | $2.7M | +0.5% |
| SG&A Expense | $11.5M | +12.1% |
| Operating Income | -$1.9M | -22.1% |
| Pre-tax Income | -$3.7M | -32.8% |
| Income Tax | -$589K | -193.9% |
| Net Income | -$3.1M |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Accounts Receivable | $4.4M | -2.4% |
| Inventory | $582K | -54.7% |
| Current Assets | $10.2M | -2.8% |
| Total Assets | $37.7M | -6.4% |
| Current Liabilities | $6.5M | +13.7% |
| Long-term Debt | $42.6M | -1.1% |
| Total Liabilities | $49.3M | +1.1% |
| Line Item | 2024-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.9M | +26.7% |
| Investing Cash Flow | -$3.8M | +15.8% |
| Financing Cash Flow | -$365K | +28.6% |
| +9.1% |
| EPS (Basic) | -$0.26 | +13.3% |
| EPS (Diluted) | -$0.26 | -186.7% |
| Stockholders' Equity |
| -$11.6M |
| -36.7% |